No association between the alpha-2 macroglobulin I1000V polymorphism and Alzheimer's disease.

Wavrant-DeVrièze, F; Rudrasingham, V; Lambert, J C; Chakraverty, S; Kehoe, P; Crook, R; Amouyel, P; Wu, W; Holmans, P; Rice, F; Pérez-Tur, J; Frigard, B; Morris, J C; Carty, S; Cottel, D; Tunstall, N; Lovestone, S; Petersen, R C; Chartier-Harlin, M C; Goate, A; Owen, M J; Williams, J; Hardy, J

Wavrant-DeVrièze, F; Rudrasingham, V; Lambert, J C; Chakraverty, S; Kehoe, P; Crook, R; Amouyel, P; Wu, W; Holmans, P; Rice, F; Pérez-Tur, J; Frigard, B; Morris, J C; Carty, S; Cottel, D; Tunstall, N; Lovestone, S; Petersen, R C; Chartier-Harlin, M C; Goate, A; Owen, M J; Williams, J; Hardy, J.

Affiliation

Wavrant-DeVrièze F; Mayo Clinic Jacksonville, FL 32084, USA.

Neurosci Lett ; 262(2): 137-9, 1999 Mar 05.

Article in En | MEDLINE | ID: mdl-10203250

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Polymorphism, Genetic / Alpha-Macroglobulins / Alzheimer Disease / Genetic Linkage Type of study: Observational_studies / Risk_factors_studies Limits: Humans / Middle aged Language: En Journal: Neurosci Lett Year: 1999 Document type: Article Affiliation country: Country of publication:

Search on Google

Add to My VHL

XML

PubMed Links